We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+27.94%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$556M
AUM Growth
+$97.3M
Cap. Flow
-$17.8M
Cap. Flow %
-3.2%
Top 10 Hldgs %
43.97%
Holding
352
New
25
Increased
29
Reduced
61
Closed
17

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$2.79M
2
RTX icon
RTX Corp
RTX
+$1.69M
3
FIVN icon
FIVE9
FIVN
+$1.44M
4
LVS icon
Las Vegas Sands
LVS
+$1.44M
5
QSR icon
Restaurant Brands International
QSR
+$1.42M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.02M
2
AMZN icon
Amazon
AMZN
+$2.94M
3
XYL icon
Xylem
XYL
+$2.82M
4
V icon
Visa
V
+$2.28M
5
HON icon
Honeywell
HON
+$1.98M

Sector Composition

Rank Sector Weight
1 Technology 31.82%
2 Healthcare 14.48%
3 Consumer Discretionary 14.42%
4 Communication Services 12.19%
5 Financials 12.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
101
Sarepta Therapeutics
SRPT
$1.57B
$704K 0.13%
4,393
– –
PXD
102
DELISTED
Pioneer Natural Resource Co.
PXD
$655K 0.12%
6,665
– –
COUP
103
DELISTED
Coupa Software Incorporated
COUP
$652K 0.12%
2,353
-998
-30% -$201K
MRCY icon
104
Mercury Systems
MRCY
$5.83B
$613K 0.11%
7,788
– –
LHCG
105
DELISTED
LHC Group LLC
LHCG
$594K 0.11%
3,409
– –
CWST icon
106
Casella Waste Systems
CWST
$5.71B
$577K 0.1%
11,066
– –
INTC icon
107
Intel
INTC
$455B
$563K 0.1%
9,404
– –
RETA
108
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$543K 0.1%
3,483
– –
BCPC
109
Balchem Corp
BCPC
$5.38B
$527K 0.09%
5,551
– –
WING icon
110
Wingstop
WING
$3.53B
$519K 0.09%
3,735
-978
-21% -$114K
EHC icon
111
Encompass Health
EHC
$11B
$510K 0.09%
10,301
– –
KKR icon
112
KKR & Co
KKR
$91.1B
$501K 0.09%
16,221
– –
SAIA icon
113
Saia
SAIA
$9.25B
$500K 0.09%
4,501
– –
PEN icon
114
Penumbra
PEN
$12.6B
$493K 0.09%
2,758
– –
TXRH icon
115
Texas Roadhouse
TXRH
$13.5B
$488K 0.09%
9,290
– –
NTRA icon
116
Natera
NTRA
$38.3B
$473K 0.09%
9,493
– –
ABBV icon
117
AbbVie
ABBV
$443B
$469K 0.08%
4,777
+226
+5% +$19.9K
CDLX icon
118
Cardlytics
CDLX
$21.7M
$434K 0.08%
620
– –
EVBG
119
DELISTED
Everbridge, Inc. Common Stock
EVBG
$434K 0.08%
3,140
-1,381
-31% -$179K
ROST icon
120
Ross Stores
ROST
$80.5B
$425K 0.08%
+4,985
New +$452K
CSCO icon
121
Cisco
CSCO
$457B
$407K 0.07%
8,736
– –
HQY icon
122
HealthEquity
HQY
$8.41B
$390K 0.07%
6,644
– –
CCMP
123
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$386K 0.07%
2,756
– –
SSD icon
124
Simpson Manufacturing
SSD
$7.72B
$383K 0.07%
4,538
+935
+26% +$69K
INSP icon
125
Inspire Medical Systems
INSP
$1.45B
$376K 0.07%
4,324
– –
3 4
5
6 7

Similar funds

AG
Ascent Group Virginia Beach, Virginia $2.89B AUM 19.6% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
PFM
Potomac Fund Management Miami, Florida $2.88B AUM 15.75% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $2.88B AUM 18.53% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return
CCM
Chilton Capital Management Houston, Texas $2.87B AUM 25.44% 1-Year Est. Return
HCC
Hirtle Callaghan & Co West Conshohocken, Pennsylvania $2.92B AUM 17.65% 1-Year Est. Return

Silvant Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Silvant Capital Management held 352 positions worth $556M, up 21% from $459M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Silvant Capital Management withdrew a net $17.8M in Q2 2020, closing 17 positions and reducing 61 holdings. Its most notable exit was Xylem, an estimated $2.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in Las Vegas Sands worth $1.4M.

  • Silvant Capital Management's largest Q2 2020 buy was Las Vegas Sands: 30,631 shares worth $1.4M.
  • Silvant Capital Management added most to Boeing in Q2 2020, an estimated $2.79M increase.
  • Silvant Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $3.02M.
  • Silvant Capital Management fully exited Xylem in Q2 2020, selling an estimated $2.82M.
  • Silvant Capital Management's ten largest holdings make up 44% of its $556M portfolio in Q2 2020.
  • Silvant Capital Management opened 25 new positions and closed 17 in Q2 2020.
  • Silvant Capital Management's portfolio value rose 21% quarter-over-quarter to $556M.

Based on Silvant Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.